Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKeystone Positive Change Investment Trust Regulatory News (KPC)

  • This share is currently suspended. It was suspended at a price of 223.00
  • There is currently no data for KPC

Scheme of Reconstruction

30 Sep 2024 07:00

RNS Number : 0920G
Keystone Positive Change I.T. PLC
30 September 2024
 

30 September 2024

 

Keystone Positive Change Investment Trust plc (KPC) ("Keystone" or the "Company")

 

Legal Entity Identifier: 5493002H3JXLXLIGC563

 

 

Intention to propose a scheme of reconstruction

 

On 9 September 2024 the Company announced that the Board had concluded, notwithstanding its confidence in the long-term prospects for Baillie Gifford's "Positive Change" strategy adopted by the Company in early 2021, that the interests of Shareholders may be best served by implementing a transaction in the near term.

 

Having considered additional feedback from Shareholders, and the Company's options to retain exposure to a global impact strategy, the Board today announces it has decided to propose a scheme of reconstruction and winding-up of the Company (the "Scheme") under which Shareholders will have the option to receive shares in the Baillie Gifford Positive Change Fund, an FCA authorised open-ended investment company with assets of c.£1.8bn, or an uncapped cash exit at a modest discount to the formula asset value (the "FAV") calculated for the purposes of the Scheme.

 

Karen Brade, Chair, commented:

 

"The Board retains a high degree of conviction in the Positive Change strategy and believes it is well suited to the investment trust structure which enables the Managers to access the significant impact opportunities available from committing primary capital to private companies and investing in less liquid public companies. However, we recognise that the Company has not received sufficient support from Shareholders to allow the strategy the time needed to play out over the period to the February 2027 continuation vote that we recently introduced. The Board has therefore reluctantly agreed to propose the Scheme, which will provide Shareholders with an opportunity to continue their investment through the rollover option."

 

The Board reiterates its previous statement that the Scheme would need to take into account the illiquidity of the Company's five private company investments, which comprised c.4.3% of the portfolio as at 31 August 2024. The Board has been advised that these investments are unlikely to be realisable within the timeframe of the Scheme and that, if this proves correct, their value would not be incorporated in the FAV with the unrealised investments instead being carried forward into the winding-up and with any net proceeds received from the realisation of these investments being distributed to all Shareholders at a later date.

 

The City Code on Takeovers and Mergers is not expected to apply to the Scheme.

 

It is expected that the Scheme will take effect during the first quarter of 2025. A further announcement will be made in due course.

 

Given the Company's circumstances, it has regrettably been agreed that Ranjan Ramparia will not as previously announced be appointed as a non-executive Director. The Board thanks Ranjan for her engagement with the Company.

 

For further information please contact:

 

Karen Brade, Keystone Chair

Email: trustenquiries@bailliegifford.com

 

Nathan Brown / Matt Goss, Deutsche Numis

Tel: 020 7260 1426/1642

 

Naomi Cherry / Alex Blake, Baillie Gifford

Tel: 0131 275 2000

 

Jonathan Atkins, Director, Four Communications

Tel: 0203 920 0555 or 07872 495396

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRFLFVEAAIDFIS
Date   Source Headline
19th Mar 20258:44 amRNSResults of Elections
18th Mar 202512:22 pmRNSNet Asset Value(s)
18th Mar 20257:30 amRNSSuspension - Keystone Positive Change I.T. PLC
17th Mar 20251:46 pmRNSResults of Meetings Adjourned from 27 January 2025
17th Mar 202512:00 pmRNSNet Asset Value(s)
14th Mar 202512:20 pmRNSNet Asset Value(s)
13th Mar 202511:20 amRNSNet Asset Value(s)
12th Mar 202511:15 amRNSNet Asset Value(s)
11th Mar 20256:00 pmRNSKeystone Positive Change Investment Trust
11th Mar 202512:33 pmRNSNet Asset Value(s)
10th Mar 202512:07 pmRNSNet Asset Value(s)
7th Mar 202512:30 pmRNSNet Asset Value(s)
6th Mar 202511:27 amRNSNet Asset Value(s)
5th Mar 202511:28 amRNSNet Asset Value(s)
4th Mar 202511:50 amRNSNet Asset Value(s)
3rd Mar 20251:34 pmRNSNet Asset Value(s)
28th Feb 202512:56 pmRNSNet Asset Value(s)
27th Feb 202512:08 pmRNSNet Asset Value(s)
26th Feb 202511:48 amRNSNet Asset Value(s)
25th Feb 202511:23 amRNSNet Asset Value(s)
24th Feb 202512:28 pmRNSNet Asset Value(s)
21st Feb 202512:08 pmRNSNet Asset Value(s)
20th Feb 20251:12 pmRNSNet Asset Value(s)
19th Feb 20252:42 pmRNSReconvening the Scheme Meetings and convening AGM
19th Feb 202512:00 pmRNSNet Asset Value(s)
18th Feb 202512:06 pmRNSNet Asset Value(s)
17th Feb 20252:56 pmRNSNet Asset Value(s)
14th Feb 202512:33 pmRNSNet Asset Value(s)
13th Feb 202511:23 amRNSNet Asset Value(s)
12th Feb 202511:17 amRNSNet Asset Value(s)
11th Feb 202511:42 amRNSNet Asset Value(s)
10th Feb 20251:15 pmRNSRelaunch of the Scheme
10th Feb 202511:38 amRNSNet Asset Value(s)
7th Feb 20254:49 pmRNSAdjournment of Scheme Meeting
7th Feb 202512:15 pmRNSNet Asset Value(s)
6th Feb 202511:02 amRNSNet Asset Value(s)
5th Feb 202510:59 amRNSNet Asset Value(s)
4th Feb 202511:55 amRNSNet Asset Value(s)
3rd Feb 20253:24 pmRNSResult of Requisitioned General Meeting
3rd Feb 20252:02 pmRNSNet Asset Value(s)
3rd Feb 202512:08 pmRNSTotal Voting Rights
31st Jan 202512:04 pmRNSNet Asset Value(s)
30th Jan 202512:18 pmRNSNet Asset Value(s)
29th Jan 202511:42 amRNSNet Asset Value(s)
28th Jan 20254:55 pmRNSTransaction in Own Shares
28th Jan 202512:28 pmRNSNet Asset Value(s)
27th Jan 20255:32 pmRNSTransaction in Own Shares
27th Jan 20254:11 pmRNSAnnouncement of Adjourned Meetings
27th Jan 202512:13 pmRNSNet Asset Value(s)
24th Jan 202511:58 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.